Kentucky Retirement Systems Insurance Trust Fund’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,944
| Closed | -$924K | – | 584 |
|
|
2024
Q4 | $924K | Buy |
+6,944
| New | +$924K | 0.16% | 155 |
|
|
2021
Q3 | – | Sell |
-5,753
| Closed | -$1.06M | – | 494 |
|
|
2021
Q2 | $1.06M | Sell |
5,753
-328
| -5% | -$56.3K | 0.11% | 188 |
|
|
2021
Q1 | $930K | Buy |
6,081
+1,309
| +27% | +$202K | 0.1% | 213 |
|
|
2020
Q4 | $746K | Sell |
4,772
-972
| -17% | -$125K | 0.08% | 244 |
|
|
2020
Q3 | $657K | Buy |
5,744
+313
| +6% | +$33.8K | 0.09% | 223 |
|
|
2020
Q2 | $610K | Sell |
5,431
-1,277
| -19% | -$136K | 0.1% | 211 |
|
|
2020
Q1 | $602K | Buy |
6,708
+1,466
| +28% | +$144K | 0.09% | 216 |
|
|
2019
Q4 | $567K | Sell |
5,242
-48
| -0.9% | -$5.13K | 0.09% | 241 |
|
|
2019
Q3 | $518K | Buy |
5,290
+614
| +13% | +$69.2K | 0.09% | 247 |
|
|
2019
Q2 | $612K | Buy |
4,676
+233
| +5% | +$30K | 0.12% | 189 |
|
|
2019
Q1 | $601K | Buy |
4,443
+30
| +0.7% | +$3.73K | 0.13% | 181 |
|
|
2018
Q4 | $430K | Buy |
4,413
+203
| +5% | +$24K | 0.11% | 212 |
|
|
2018
Q3 | $585K | Buy |
4,210
+20
| +0.5% | +$2.51K | 0.13% | 183 |
|
|
2018
Q2 | $520K | Sell |
4,190
-885
| -17% | -$103K | 0.12% | 192 |
|
|
2018
Q1 | $566K | Sell |
5,075
-858
| -14% | -$103K | 0.11% | 208 |
|
|
2017
Q4 | $710K | Sell |
5,933
-5
| -0.1% | -$609 | 0.12% | 198 |
|
|
2017
Q3 | $833K | Sell |
5,938
-212
| -3% | -$28.8K | 0.15% | 171 |
|
|
2017
Q2 | $748K | Buy |
6,150
+76
| +1% | +$8.85K | 0.13% | 187 |
|
|
2017
Q1 | $736K | Sell |
6,074
-1,186
| -16% | -$153K | 0.14% | 180 |
|
|
2016
Q4 | $888K | Buy |
7,260
+3
| +0% | +$367 | 0.14% | 174 |
|
|
2016
Q3 | $889K | Sell |
7,257
-1,788
| -20% | -$230K | 0.14% | 171 |
|
|
2016
Q2 | $1.06M | Sell |
9,045
-1,149
| -11% | -$163K | 0.14% | 167 |
|
|
2016
Q1 | $1.42M | Buy |
10,194
+1,754
| +21% | +$258K | 0.18% | 139 |
|
|
2015
Q4 | $1.61M | Buy |
8,440
+884
| +12% | +$154K | 0.24% | 100 |
|
|
2015
Q3 | $1.18M | Buy |
7,556
+252
| +3% | +$46K | 0.21% | 118 |
|
|
2015
Q2 | $1.32M | Buy |
7,304
+805
| +12% | +$139K | 0.22% | 111 |
|
|
2015
Q1 | $1.13M | Sell |
6,499
-547
| -8% | -$99K | 0.19% | 127 |
|
|
2014
Q4 | $1.3M | Buy |
7,046
+102
| +1% | +$18.9K | 0.2% | 122 |
|
|
2014
Q3 | $924K | Sell |
6,944
-21
| -0.3% | -$3.45K | 0.16% | 155 |
|
|
2014
Q2 | $1.09M | Buy |
6,965
+144
| +2% | +$22.7K | 0.18% | 145 |
|
|
2014
Q1 | $1.04M | Sell |
6,821
-123
| -2% | -$19.6K | 0.18% | 139 |
|
|
2013
Q4 | $924K | Sell |
6,944
-23
| -0.3% | -$2.76K | 0.16% | 155 |
|
|
2013
Q3 | $809K | Buy |
+6,967
| New | +$764K | 0.15% | 163 |
|
Kentucky Retirement Systems Insurance Trust Fund's ALXN Position: Q1 2025 in Review
Kentucky Retirement Systems Insurance Trust Fund sold out of Alexion Pharmaceuticals (ALXN) in Q1 2025, closing a stake of 6,944 shares — an estimated $924K sold.
Kentucky Retirement Systems Insurance Trust Fund first reported a position in ALXN in Q3 2013 and held it in 33 quarters. The position peaked at $1.61M in Q4 2015. 0 funds tracked by Wall St. Rank hold ALXN as of Q1 2025.
- Kentucky Retirement Systems Insurance Trust Fund reported no remaining Alexion Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
- Kentucky Retirement Systems Insurance Trust Fund sold 6,944 Alexion Pharmaceuticals shares in Q1 2025, an estimated $924K.
- Kentucky Retirement Systems Insurance Trust Fund first reported a position in Alexion Pharmaceuticals in Q3 2013 and held it in 33 quarters.
- Kentucky Retirement Systems Insurance Trust Fund's Alexion Pharmaceuticals position peaked at $1.61M in Q4 2015.
- 0 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2025.
Based on Kentucky Retirement Systems Insurance Trust Fund's 13F filing for Q1 2025, filed 22 Apr 2025.